Press Releases May 19, 2026 09:00 AM

Nasdaq Halts TJGC Group Limited

Nasdaq halts trading in TJGC Group Limited pending additional disclosures

By Leila Farooq
Share
Twitter Reddit Facebook LinkedIn
TJGC

Nasdaq has halted trading in TJGC Group Limited shares pending the company's provision of additional information. Trading stopped on May 15, 2026, with shares last closing at $2.19. The halt will remain until the company satisfies Nasdaq's information requests.

Nasdaq Halts TJGC Group Limited
TJGC
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Nasdaq halted TJGC Group Limited trading on May 15, 2026, due to requests for additional information.
  • The company's shares last traded at $2.19 before the halt.
  • Trading remains suspended pending the company's full compliance with Nasdaq's requests.

NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading is halted in TJGC Group Limited (Nasdaq: TJGC) for additional information requested from the company. Nasdaq halted TJGC at 18:50:47 on May 15, 2026; the last closing price of the company’s ordinary shares was $2.19. 

Trading will remain halted until TJGC Group Limited has fully satisfied Nasdaq’s request for additional information.

For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotesSM on the Nasdaq® Web site.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com.

Nasdaq Contact:

Nasdaq MarketWatch
nasdaqmarketwatch@nasdaq.com

NDAQO


Risks

  • Investors face uncertainty due to the lack of information, possibly impacting share price negatively.
  • Potential regulatory concerns or disclosures could adversely affect the company's valuation.
  • Extended trading suspension may reduce liquidity and investor confidence.

More from Press Releases

Prelude Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference Sep 11, 2026 NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Begins Training and Deployment of Zeta Surgical's FDA-Cleared Robotic TMS System Sep 11, 2026 SFL - Charter Extension for 6 x 15,400 TEU vessels adding $750 Million Backlog Sep 11, 2026 MoneyHero Group Reports Unaudited Second Quarter 2026 Results Sep 11, 2026 Liberty Global Tech Ventures Invests in AI Inference Hardware and Software Company, Positron AI Sep 11, 2026